Oct 1 (Reuters) - ENSEM THERAPEUTICS: * ENSEM THERAPEUTICS ANNOUNCES ETX-636 GRANTED FAST TRACK DESIGNATION BY THE FDA FOR ADVANCED BREAST CANCER Source text: Further company coverage: [ ] (The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
